OO-mob

OXU-001 is being developed to provide retinal specialists with a potent, long-lasting, safe, and broad-acting anti-edema and anti-inflammatory for the treatment of DME, RVO and uveitis. Given this product profile and its delivery to the middle layers of the eye via Oxulumis, there is potential to expand OXU-001 development to radiation maculopathy and specifically to …

OXU-001 mob (Radiation maculopathy) Read More »